Definitive Contract 75N91021C00043
Award Date
9/16/21
Potential Completion Date
9/15/22
Potential Value
$453K
Federal Agency
National Cancer Institute
Awardee
Pistevo Decision LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20170, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $225,000.00 firm-fixed-price contract to Klesis, LLC, a small business, to conduct research and development on "Enabling Clinical Decision Support for Guideline Based Cancer Symptom Management" under its Small Business Innovation Research (SBIR) program. This contract supports the overall goals of the SBIR program to stimulate innovation, strengthen the role of small businesses...
This federal contract award, with ID 75N91021C00050, was made by the National Cancer Institute (NCI) to Pieces Technologies Inc., a small business, for a Firm Fixed Price SBIR Phase I research contract valued at $400,000.00. The contract is focused on "Screening for Social Determinants of Health and Interventions to Improve Outcomes in Cancer Patients". This award is part of the NCI's Small Business Innovation Research (SBIR) program, which aims to stimulate technological innovation...
This SBIR Phase I contract from the National Cancer Institute, valued at $361,254, was awarded to Avident Health LLC. The firm will develop its MyNavigator mHealth application for use in patient navigator breast cancer care workflows, as requested under NIH Solicitation 406. This total small business set-aside solicitation sought proposals for Phase I and Phase II SBIR contracts to conduct R&D supporting NIH and CDC agency missions, including alternatives to cell culture materials and cancer...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...